INTENDED FOR UK AND IRELAND HEALTHCARE PROFESSIONALS Patient InformationHomePrescribing information

the CHIESI cf portfolio
LIVING & BREATHING CYSTIC FIBROSIS
Quinsair® (levofloxacin) is the first inhaled quinolone for the management of chronic pulmonary infections due to Pseudomonas aeruginosa in adult patients with cystic fibrosis.1

Find out more

1.Quinsair Summary of Product Characteristics, Chiesi Limited.
2.Bramitob Summary of Product Characteristics, Chiesi Limited.
3.Bronchitol Summary of Product Characteristics, Pharmaxis Europe Limited.

IE-CF-2000116  | Oct 2020